NeuroPace
NeuroPace, Inc. is a U.S.-based medical technology firm. It specializes in the creation and distribution of the RNS system, an advanced brain-responsive neuromodulation device designed to manage medically intractable focal epilepsy. This innovative system delivers tailored, real-time therapy directly to the source of seizures. Furthermore, the RNS system continuously records brain activity, providing medical professionals with the capability to monitor patients both on-site and remotely. The company supplies its devices to hospitals for both initial surgical implantations and subsequent replacement procedures. NeuroPace, Inc. was founded in 1997 and maintains its corporate headquarters in Mountain View, California.
Visit website
LLY Eli Lilly and Company |
$1139.65 | -1.23% |
JNJ Johnson & Johnson |
$256.11 | -1.42% |
ABBV AbbVie |
$260.91 | 0.45% |
MRK Merck & Co. |
$143.38 | -0.27% |
UNH UnitedHealth Group Incorp… |
$368.09 | 0.81% |